GlassScriptPhysician profile
Christie J Howard
NPI 1457797045
$1,453.00
in general payments reported to CMS, 2019-2025
21 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.27 · 2022: $322 · 2023: $604 · 2024: $366 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $341.55 | 2023 | Cabometyx |
| Novo Nordisk INC | $186.53 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $127.39 | 2022-2025 | |
| Qol Medical, LLC | $123.73 | 2024 | Sucraid |
| Abbvie INC. | $113.85 | 2022-2023 | |
| Glaxosmithkline, LLC. | $72.36 | 2022-2025 | Bexsero, Shingrix, Arexvy |
| Genentech USA, INC. | $59.56 | 2024 | Venclexta, Tecentriq, Alecensa |
| Exact Sciences Corporation | $52.88 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $50.28 | 2023-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $47.55 | 2022 | |
| Amgen INC. | $44.77 | 2022-2023 | Repatha |
| Boston Scientific Corporation | $38.82 | 2022-2024 | Watchman Flx |
| Lilly USA, LLC | $34.23 | 2023-2024 | Zepbound, Mounjaro |
| Mentor Worldwide LLC | $26.21 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.67 | 2023 | Ofev |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $24.80 | 2025 | Leqembi |
| Dynavax Technologies Corporation | $20.28 | 2023 | Heplisav-B |
| Astellas Pharma US INC | $17.25 | 2023 | Veozah |
| Sanofi Pasteur INC. | $17.01 | 2023 | |
| Nevro Corp. | $15.98 | 2023 | Senza |
| Novartis Pharmaceuticals Corporation | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christie Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.